Hereditary Multiple Exostosis
Multiple hereditary exostosis, is a genetic condition that is often transmitted to a child by one parent, but it can also be caused by a genetic mutation. The
gene for multiple hereditary exostosis produces a protein that influences bone growth and development, causing bony
tumors called exostosis. Multiple hereditary exostosis is usually diagnosed around age 3 or 4, when the first exostosis appears. The exostoses are more protuberant as the child grows but stops developing as soon as a child hits adulthood. The
tumors can cause pain when they arise under easily infected tendons or areas. First, a physical exam will be performed to help determine the
tumor areas and the number of bones involved. X-rays will then be taken from any area where there is discomfort. A CT scan can be used to further evaluate bony tumors, and an MRI scan can be ordered to rule out any intrauterine growth. The treatment of
hereditary multiple exostosis is the surgical removal of any
tumors that cause pain or discomfort, or disrupt the child's movement.
High Impact List of Articles
-
Prevalence of aminoglycoside resistance genes in Pseudomonas aeruginosa isolated from a tertiary care hospital in Makkah, KSA
Atif H Asghar & Omar B Ahmed*
Research Article: Clinical Practice
-
Prevalence of aminoglycoside resistance genes in Pseudomonas aeruginosa isolated from a tertiary care hospital in Makkah, KSA
Atif H Asghar & Omar B Ahmed*
Research Article: Clinical Practice
-
Knowledge, attitude, practice and associated factors towards post exposure prophylaxis to HIV infection among health care professionals in Debre Markos town public health institutions, Northwest Ethiopia, 2017
Biyadgie Aschale, Yenesew Tamir, Girma Alem*
Research Article: Clinical Practice
-
Knowledge, attitude, practice and associated factors towards post exposure prophylaxis to HIV infection among health care professionals in Debre Markos town public health institutions, Northwest Ethiopia, 2017
Biyadgie Aschale, Yenesew Tamir, Girma Alem*
Research Article: Clinical Practice
-
Treating cystic fibrosis infection, inflammation and ion channels
J Stuart Elborn
Foreword: Clinical Practice
-
Treating cystic fibrosis infection, inflammation and ion channels
J Stuart Elborn
Foreword: Clinical Practice
-
Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention
Eduardo L Franco and Jorma Paavonen
Foreword: Clinical Practice
-
Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention
Eduardo L Franco and Jorma Paavonen
Foreword: Clinical Practice
-
Tenofovir disoproxil fumarate for the treatment of hepatitis B virus infection: pharmacokinetics and clinical efficacy
David J Quan and Marion G Peters
Drug Evaluation: Clinical Practice
-
Tenofovir disoproxil fumarate for the treatment of hepatitis B virus infection: pharmacokinetics and clinical efficacy
David J Quan and Marion G Peters
Drug Evaluation: Clinical Practice
Relevant Topics in Clinical